+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Intracranial Hypertension Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767610
  • Report
  • 57 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • PT Kalbe Farma Tbk
  • MORE
The global clinical trial report- “2019 Intracranial Hypertension Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Intracranial Hypertension. It presents in-depth analysis of Intracranial Hypertension clinical trials across markets and companies. The research work is for providing complete understanding into trends in Intracranial Hypertension.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Intracranial Hypertension clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Intracranial Hypertension

The research work is prepared through extensive and continuous research on Intracranial Hypertension trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Intracranial Hypertension patients are identified
  • The report includes panorama of Intracranial Hypertension clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Intracranial Hypertension clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca Plc
  • PT Kalbe Farma Tbk
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Intracranial Hypertension Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Intracranial Hypertension Clinical Trials by Region
2.2.2 Average Enrollment of Intracranial Hypertension Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Intracranial Hypertension Treatment, 2019

3. Region wise Intracranial Hypertension Clinical Trials
3.1 Asia Pacific Intracranial Hypertension Clinical Trials by Country
3.2 Europe Intracranial Hypertension Clinical Trials by Country
3.3 North America Intracranial Hypertension Clinical Trials by Country
3.4 Middle East and Africa Intracranial Hypertension Clinical Trials by Country
3.5 South and Central America Intracranial Hypertension Clinical Trials by Country

4. Intracranial Hypertension Clinical Trial Trends
4.1 Start Year wise Intracranial Hypertension Clinical Trials
4.2 Phase wise Intracranial Hypertension Clinical Trials
4.3 Trial Status wise Intracranial Hypertension Clinical Trials
4.4 Trial Type wise Intracranial Hypertension Clinical Trials

5. Intracranial Hypertension Average Enrollment Trends
5.1 Average Enrollment in Intracranial Hypertension Trials by Year
5.2 Average Enrollment in Intracranial Hypertension Trials by Phase
5.3 Average Enrollment in Intracranial Hypertension Trials by Status
5.4 Average Enrollment in Intracranial Hypertension Trials by Type of Trial

6. Companies Participating in Intracranial Hypertension Clinical Trials
6.1 Intracranial Hypertension Trials by Sponsor Type
6.2 Intracranial Hypertension Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Intracranial Hypertension Trials- Phase 1
7.2 Intracranial Hypertension Trials- Phase 2
7.3 Intracranial Hypertension Trials- Phase 3
7.4 Intracranial Hypertension Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Intracranial Hypertension Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Figure 5: Europe - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Figure 7: North America - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Figure 9: Intracranial Hypertension Clinical Trials by Phase
Figure 10: Intracranial Hypertension Clinical Trials by Trial Status
Figure 11: Intracranial Hypertension Clinical Trials by Type
Figure 12: Intracranial Hypertension Clinical Trials by Sponsor Type
Figure 13: Intracranial Hypertension Clinical Trials by Leading Sponsors
Figure 14: Intracranial Hypertension Average Enrollment by Phase
Figure 15: Intracranial Hypertension Average Enrollment by Trial Status
Figure 16: Intracranial Hypertension Average Enrollment by Type
Figure 17: Intracranial Hypertension- Average Enrolment by Type of Sponsors
Figure 18: Intracranial Hypertension- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Intracranial Hypertension Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Table 5: Europe - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Table 7: North America - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Intracranial Hypertension Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Intracranial Hypertension Average Enrollment by Phase
Table 15: Intracranial Hypertension Average Enrollment by Trial Status
Table 16: Intracranial Hypertension Average Enrollment by Type
Table 17: Intracranial Hypertension- Average Enrolment by Type of Sponsors
Table 18: Intracranial Hypertension- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AstraZeneca Plc
  • Centre Hospitalier Universitaire de Nice
  • PT Kalbe Farma Tbk
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4767610
Adroll
adroll